| Phase 1/21 trial |
|
Phase 1/2
|
NCT03887169 |
Sep 2019 → Jun 2020 |
inborn mitochondrial metabolism disorder, pulmonary alveolar proteinosis |
Assistance Publique - Hôpitaux de Paris |
Completed
|
No outcome recorded
|
| Phase 21 trial |
|
Phase 2
|
NCT00840047 |
Jul 2009 → Jul 2027 expected |
Ewing sarcoma, Hodgkins lymphoma, brain stem glioma, craniopharyngioma +6 |
St. Jude Children's Research Hospital |
Active not recruiting
|
No outcome recorded
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT02824419 |
May 2016 → Feb 2017 |
pulmonary sarcoidosis |
Turku University Hospital |
Terminated
|
No outcome recorded
|
| Phase 31 trial |
|
Phase 3
|
NCT00032695 |
— |
AIDS-related disorder, spinal cord disorder |
National Institute of Neurological Disorders and Stroke (NINDS) |
Completed
|
No outcome recorded
|
| Phase not applicable3 trials |
| — |
NCT00253773 |
Jan 2005 → Nov 2007 |
disorder of defective peroxisome oxidative status |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Completed
|
No outcome recorded
|
| — |
NCT00253760 |
Feb 2004 → Feb 2007 |
diabetes mellitus, heart disorder |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Completed
|
No outcome recorded
|
| — |
NCT00597246 |
May 2003 → Nov 2019 |
brain cancer |
Memorial Sloan Kettering Cancer Center |
Completed
|
No outcome recorded
|